...
search icon
dmac-img

DiaMedica Therapeutics Inc Share Price

DMAC
NAQ
$8.7
+$0.17
(1.99%)
1D
Industry: Biotechnology Sector: Health Care

DiaMedica Therapeutics Inc Analyst Forecast

DiaMedica Therapeutics Inc Share Price Chart

DiaMedica Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$444.22M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
220.69K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.08
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.19 L
$10.42 H
$8.7

About DiaMedica Therapeutics Inc, Common Stock

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. more

Industry: BiotechnologySector: Health Care

DiaMedica Therapeutics Inc Stock Returns

Time FrameDMACSectorS&P500
1-Week Return4.07%1.51%-1.5%
1-Month Return17.25%1.46%0.6%
3-Month Return35.73%3.94%2.43%
6-Month Return51.04%16.03%6.01%
1-Year Return41.23%9.1%11.48%
3-Year Return417.86%19.46%67.52%
5-Year Return-16.51%35.29%73.75%
10-Year Return214.99%137.42%254.46%

DiaMedica Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue21.00K24.00K25.00K30.00K39.00K[{"date":"2020-12-31","value":53.85,"profit":true},{"date":"2021-12-31","value":61.54,"profit":true},{"date":"2022-12-31","value":64.1,"profit":true},{"date":"2023-12-31","value":76.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(21.00K)(24.00K)(25.00K)(30.00K)(39.00K)[{"date":"2020-12-31","value":-2100000,"profit":false},{"date":"2021-12-31","value":-2400000,"profit":false},{"date":"2022-12-31","value":-2500000,"profit":false},{"date":"2023-12-31","value":-3000000,"profit":false},{"date":"2024-12-31","value":-3900000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses12.70M13.65M14.00M21.27M26.68M[{"date":"2020-12-31","value":47.6,"profit":true},{"date":"2021-12-31","value":51.15,"profit":true},{"date":"2022-12-31","value":52.48,"profit":true},{"date":"2023-12-31","value":79.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(12.70M)(13.65M)(14.00M)(21.27M)(26.68M)[{"date":"2020-12-31","value":-1269900000,"profit":false},{"date":"2021-12-31","value":-1364600000,"profit":false},{"date":"2022-12-31","value":-1400100000,"profit":false},{"date":"2023-12-31","value":-2126700000,"profit":false},{"date":"2024-12-31","value":-2668100000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(12.27M)(13.56M)(13.65M)(19.34M)(24.41M)[{"date":"2020-12-31","value":-1226500000,"profit":false},{"date":"2021-12-31","value":-1356400000,"profit":false},{"date":"2022-12-31","value":-1364800000,"profit":false},{"date":"2023-12-31","value":-1933800000,"profit":false},{"date":"2024-12-31","value":-2441400000,"profit":false}]
Income Taxes27.00K28.00K28.00K43.00K30.00K[{"date":"2020-12-31","value":62.79,"profit":true},{"date":"2021-12-31","value":65.12,"profit":true},{"date":"2022-12-31","value":65.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":69.77,"profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.29M)(13.59M)(13.68M)(17.97M)(24.44M)[{"date":"2020-12-31","value":-1229200000,"profit":false},{"date":"2021-12-31","value":-1359200000,"profit":false},{"date":"2022-12-31","value":-1367600000,"profit":false},{"date":"2023-12-31","value":-1797100000,"profit":false},{"date":"2024-12-31","value":-2444400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.29M)(13.59M)(13.68M)(19.38M)(24.44M)[{"date":"2020-12-31","value":-1229200000,"profit":false},{"date":"2021-12-31","value":-1359200000,"profit":false},{"date":"2022-12-31","value":-1367600000,"profit":false},{"date":"2023-12-31","value":-1938100000,"profit":false},{"date":"2024-12-31","value":-2444400000,"profit":false}]
EPS (Diluted)(0.78)(0.64)(0.52)(0.62)(0.60)[{"date":"2020-12-31","value":-78,"profit":false},{"date":"2021-12-31","value":-64,"profit":false},{"date":"2022-12-31","value":-52,"profit":false},{"date":"2023-12-31","value":-62,"profit":false},{"date":"2024-12-31","value":-60,"profit":false}]

DiaMedica Therapeutics Inc Ratios

DiaMedica Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

DMAC
Cash Ratio 10.50
Current Ratio 10.67

DiaMedica Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DMAC
ROA (LTM) -38.33%
ROE (LTM) -64.12%

DiaMedica Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DMAC
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

DiaMedica Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DMAC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 8.61
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is DiaMedica Therapeutics Inc share price today?

DiaMedica Therapeutics Inc (DMAC) share price today is $8.7

Can Indians buy DiaMedica Therapeutics Inc shares?

Yes, Indians can buy shares of DiaMedica Therapeutics Inc (DMAC) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DMAC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of DiaMedica Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of DiaMedica Therapeutics Inc (DMAC) via the Vested app. You can start investing in DiaMedica Therapeutics Inc (DMAC) with a minimum investment of $1.

How to invest in DiaMedica Therapeutics Inc shares from India?

You can invest in shares of DiaMedica Therapeutics Inc (DMAC) via Vested in three simple steps:

  • Click on Sign Up or Invest in DMAC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in DiaMedica Therapeutics Inc shares
What is DiaMedica Therapeutics Inc 52-week high and low stock price?

The 52-week high price of DiaMedica Therapeutics Inc (DMAC) is $10.42. The 52-week low price of DiaMedica Therapeutics Inc (DMAC) is $3.19.

What is DiaMedica Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of DiaMedica Therapeutics Inc (DMAC) is

What is DiaMedica Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of DiaMedica Therapeutics Inc (DMAC) is 8.61

What is DiaMedica Therapeutics Inc dividend yield?

The dividend yield of DiaMedica Therapeutics Inc (DMAC) is 0.00%

What is the Market Cap of DiaMedica Therapeutics Inc?

The market capitalization of DiaMedica Therapeutics Inc (DMAC) is $444.22M

What is DiaMedica Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of DiaMedica Therapeutics Inc is DMAC

How Can Investors Use DiaMedica Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of DiaMedica Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether DiaMedica Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from DiaMedica Therapeutics Inc shares for Indian investors?

When investing in DiaMedica Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the DiaMedica Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare DiaMedica Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of DiaMedica Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that DiaMedica Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top